Preveceutical Medical Inc (PREV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 07-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 175 | 36 | 19 | 0 | N/A |
| Income taxes - deferred | -8 | -40 | -97 | N/A | N/A |
| Accounts receivable | -20 | 0 | 56 | -27 | 0 |
| Accounts payable and accrued liabilities | 72 | 339 | 10 | 298 | N/A |
| Other Working Capital | 1,406 | -1,875 | -1,140 | 221 | 10 |
| Other Operating Activity | -2,618 | -6,032 | -3,147 | -1,807 | -66 |
| Operating Cash Flow | $-994 | $-7,573 | $-4,299 | $-1,315 | $-56 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -8 | -166 | -3 | -15 |
| Net Acquisitions | N/A | 0 | 1,723 | 0 | N/A |
| Purchase Sale Intangibles | -1 | -3 | -27 | -400 | N/A |
| Investing Cash Flow | $-1 | $-11 | $1,530 | $-403 | $-15 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 0 | 70 | N/A |
| Debt Issued | 804 | 1,670 | 2,901 | 14 | N/A |
| Debt Repayment | -216 | -684 | N/A | N/A | N/A |
| Common Stock Issued | 279 | 6,264 | 0 | 1,604 | 107 |
| Other Financing Activity | 0 | 295 | 20 | 0 | -8 |
| Financing Cash Flow | $867 | $7,545 | $2,921 | $1,688 | $99 |
| Exchange Rate Effect | 92 | -2 | N/A | N/A | N/A |
| Beginning Cash Position | 64 | 104 | -47 | -16 | 27 |
| End Cash Position | 28 | 64 | 104 | -47 | 55 |
| Net Cash Flow | $-128 | $-38 | $152 | $-31 | $28 |
| Free Cash Flow | |||||
| Operating Cash Flow | -994 | -7,573 | -4,299 | -1,315 | -56 |
| Capital Expenditure | -1 | -11 | -193 | -403 | -15 |
| Free Cash Flow | -995 | -7,584 | -4,492 | -1,718 | -71 |